Clinical outcomes of sofosbuvir/velpatasvir in hepatitis C virus-infected patients with end-stage renal disease on maintenance hemodialysis

• প্রধান লেখক: Li-xia Yu (লেখক), Jian-ming Ye (লেখক), Xiao-ya Yin (লেখক), Qi-feng Liu (লেখক), Qiang Sun (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Editorial Department of Journal of Clinical Nephrology, 2023-10-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Objective To evaluate the safety and efficacy of 12-week sofosbuvir/velpatasvir (SOF/VEL) in chronic hepatitis C (CHC) patients with end-stage renal disease (ESRD) on maintenance hemodialysis (MHD) in a real-world setting. Methods From October 10, 2020 to January 28, 2021, 18 CHC patients received f...